by Jeffrey Frentzen, PSP Magazine
Viora Inc, Jersey City, NJ, recently launched its FDA-cleared multifrequency and vacuum therapy bipolar radio frequency (RF) device, the Reaction, at the American Academy of Dermatologists (AAD) annual meeting and exhibition in Miami in March 2010.
The Reaction device is intended for treating cellulite, as well as body contouring and skin tightening. The unit offers a unique multiple-frequency approach to RF treatments, based on the firm’s Channeling Optimized RF Energy (CORE) technology.
Viora CEO Josef Luzon explains the reason for developing the CORE technology. “Most of the systems out there are working with one frequency,” he says. “Working with one frequency has limitations. We came up with a technology that works with three frequencies in four different modes.” This allows for better control of the depth of penetration, he adds.
This technology lets physician work in three distinct RF frequencies suitable for deep, middle, and superficial treatments—0.8 MHz, 1.7 MHz, and 2.45 MHz. In addition, the device offers a fourth mode that can dial in the other three frequencies at the same time.
As an indication of the unit’s practical application, for example, the 0.8 MHz frequency penetrates up to 18.6 mm for body contouring (with vacuum) and up to 7.2 mm for skin-tightening applications, according to the company.
